These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34654760)

  • 1. 6-Mercaptopurine to Induce Remission Despite Graft Failure Post Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia.
    Hashem H
    J Pediatr Hematol Oncol; 2022 Mar; 44(2):67. PubMed ID: 34654760
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved outcomes associated with hematopoietic stem cell transplantation for patients with juvenile myelomonocytic leukemia.
    Zhao Q; Mahadeo KM; Kapoor N; Abdel-Azim H
    Blood; 2015 Jul; 126(4):561-2. PubMed ID: 26206948
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous control of third-degree graft-versus-host disease and prevention of recurrence of juvenile myelomonocytic leukemia (JMML) with 6-mercaptopurine following fulminant JMML relapse early after KIR-mismatched bone marrow transplantation.
    Stachel DK; Leipold A; Kuhlen M; Gravou-Apostolatou C; Hirv K; Bader P; Niemeyer CM; Beck JD; Holter W
    J Pediatr Hematol Oncol; 2005 Dec; 27(12):672-4. PubMed ID: 16344675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical Study on Treatment of Juvenile Myelomonocytic Leukemia with Haploidentical-Hematopoietic Stem Cell Transplantation].
    Ding L; Zhu H; Han DM; Wang ZD; Zheng XL; Dong L; Yan HM; Liu J; Zhu L; Xue M; Guo ZK; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1524-1527. PubMed ID: 29070137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Graft Failure but Treatment Success: A Case of Reversion to Heterozygosity After Allogeneic Hematopoietic Cell Transplantation With Autologous Hematopoietic Recovery in a Child With CBL-related Juvenile Myelomonocytic Leukemia.
    Oshrine B
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):e426-e428. PubMed ID: 32032248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disappearance of minimal residual disease after the early withdrawal of immunosuppressants in a patient with juvenile myelomonocytic leukemia.
    Yanagisawa R; Matsuda K; Sakashita K; Nakazawa Y; Tanaka M; Saito S; Yoshikawa K; Kamijo T; Shiohara M; Koike K
    Pediatr Blood Cancer; 2011 Mar; 56(3):501-2. PubMed ID: 21225940
    [No Abstract]   [Full Text] [Related]  

  • 7. Transplantation for juvenile myelomonocytic leukemia: a retrospective study of 30 children treated with a regimen of busulfan, fludarabine, and melphalan.
    Yabe M; Ohtsuka Y; Watanabe K; Inagaki J; Yoshida N; Sakashita K; Kakuda H; Yabe H; Kurosawa H; Kudo K; Manabe A;
    Int J Hematol; 2015 Feb; 101(2):184-90. PubMed ID: 25504334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.
    Dvorak CC; Satwani P; Stieglitz E; Cairo MS; Dang H; Pei Q; Gao Y; Wall D; Mazor T; Olshen AB; Parker JS; Kahwash S; Hirsch B; Raimondi S; Patel N; Skeens M; Cooper T; Mehta PA; Grupp SA; Loh ML
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27034. PubMed ID: 29528181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of immunological interventions for mixed chimerism following allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia.
    Inagaki J; Fukano R; Nishikawa T; Nakashima K; Sawa D; Ito N; Okamura J
    Pediatr Blood Cancer; 2013 Jan; 60(1):116-20. PubMed ID: 22847790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies of and unique issues in hematopoietic cell transplantation for infant leukemia.
    Hunger SP; Loh KM; Baker KS; Schultz KR
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):79-83. PubMed ID: 19147083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal macrophage-related complications of juvenile myelomonocytic leukemia with a blastic crisis: an autopsy case report.
    Satoh T; Kayano H; Watanabe A; Ohta A; Endoh T; Shimizu Y; Fukushima T; Tanaka R; Yasuda M
    Int J Hematol; 2021 Oct; 114(4):517-523. PubMed ID: 34272652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image Gallery: Juvenile cutaneous chronic graft-versus-host disease presenting as bullous pemphigoid.
    Haber R; Bourrat E; Derache AF; Rivet J; Bagot M; Dalle JH; Bouaziz JD
    Br J Dermatol; 2017 Sep; 177(3):e69. PubMed ID: 28940263
    [No Abstract]   [Full Text] [Related]  

  • 13. [Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia].
    Shao Q; Wang ZD; Zheng XL; Dong L; Han DM; Yan HM; Wang HX; Duan LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1058-62. PubMed ID: 25130828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of disease recurrence after allogeneic hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: a great challenge still to be won.
    Locatelli F; Lucarelli B
    Pediatr Blood Cancer; 2013 Jan; 60(1):1-2. PubMed ID: 22976832
    [No Abstract]   [Full Text] [Related]  

  • 15. Different outcomes of allogeneic hematopoietic stem cell transplant in a pair of twins affected by juvenile myelomonocytic leukemia.
    Cesaro S; De Filippi P; Di Meglio A; Leszl A; Donska S; Zaccaron A; Cagioni C; Galavotti R; Danesino C; Aprili F; Cugno C; te Kronnie G; Zecca M; Bresolin S
    Int J Hematol; 2014 Feb; 99(2):208-12. PubMed ID: 24338706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Juvenile Myelomonocytic Leukemia: A Report from the Japan Society for Hematopoietic Cell Transplantation.
    Yoshida N; Sakaguchi H; Yabe M; Hasegawa D; Hama A; Hasegawa D; Kato M; Noguchi M; Terui K; Takahashi Y; Cho Y; Sato M; Koh K; Kakuda H; Shimada H; Hashii Y; Sato A; Kato K; Atsuta Y; Watanabe K;
    Biol Blood Marrow Transplant; 2020 May; 26(5):902-910. PubMed ID: 31790827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Second HLA-identical related hematopoietic stem cells transplantation for juvenile myelomonocytic leukemia: one case report].
    Mao JQ; Song H; Yang SL; Zhao FY; Shen DY; Tang YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jul; 15(7):591-3. PubMed ID: 23866286
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcomes of juvenile myelomonocytic leukemia patients after sequential therapy with cytarabine and 6-mercaptopurine.
    Wajid M A; Gupta AK; Das G; Sahoo D; Meena JP; Seth R
    Pediatr Hematol Oncol; 2020 Oct; 37(7):573-581. PubMed ID: 32459546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploidentical non-myeloablative stem cell transplantation as salvage for graft failure in a patient with juvenile myelomonocytic leukemia.
    Perini GF; Kerbauy FR; Fernandes JF; Santos FP; Torres MA; Ribeiro AA; Hamerschlak N
    Pediatr Blood Cancer; 2011 Dec; 57(6):1084. PubMed ID: 21748848
    [No Abstract]   [Full Text] [Related]  

  • 20. How I treat juvenile myelomonocytic leukemia.
    Locatelli F; Niemeyer CM
    Blood; 2015 Feb; 125(7):1083-90. PubMed ID: 25564399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.